https://www.selleckchem.com/products/prt4165.html
This trend was also found in larger tumors (~250mm3) where all four UCA agents significantly increased therapeutic efficacy in the high power group (p less then .01), while only Definity and SonoVue increased efficacy in the low power cohort (p less then .03). Overall, the higher power ultrasound treatment modality was more consistently effective at decreasing tumor volume and increasing vascularity characteristics. In conclusion, Sonazoid was the most consistently effective UCA at decreasing tumor volume and increasing vascularity. Thu
Like
Comment
Share
